BioCentury
ARTICLE | Financial News

Avrobio proposes $86.3M NASDAQ IPO

June 1, 2018 7:14 PM UTC

Avrobio Inc. (Cambridge, Mass.) proposed on May 25 to raise $86.3 million in an IPO underwritten by Morgan Stanley, Cowen, Wells Fargo and Wedbush PacGrow.

In February, the cell therapy company raised $60 million in a series B round led by Cormorant Asset Management and Surveyor Capital (see BioCentury, Feb. 2)...

BCIQ Company Profiles

Avrobio Inc.